Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intermedin is an Estrogen- Modulated Factor for Reducing Blood Pressure

NCT00133783 is registered in ClinicalTrials.gov with Chang Gung Memorial Hospital as lead sponsor.

NCT NCT00133783
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00133783 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intermedin is an Estrogen- Modulated Factor for Reducing Blood Pressure
Lead sponsor
Chang Gung Memorial Hospital
Phase
Observational
Overall status
Unknown status
Start date
May 31, 2005
Completion date
May 31, 2007
Enrollment
500
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, menopause